Estrella Immunopharma Stock Analysis
| ESLA Stock | 1.20 0.07 5.51% |
Estrella Immunopharma is overvalued with Real Value of 0.95 and Hype Value of 1.25. The main objective of Estrella Immunopharma stock analysis is to determine its intrinsic value, which is an estimate of what Estrella Immunopharma is worth, separate from its market price. There are two main types of Estrella Immunopharma's stock analysis: fundamental analysis and technical analysis.
The Estrella Immunopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Estrella Immunopharma's ongoing operational relationships across important fundamental and technical indicators.
Estrella |
Estrella Stock Analysis Notes
About 72.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.24. Estrella Immunopharma had not issued any dividends in recent years. To learn more about Estrella Immunopharma call Cheng Liu at 510 318 9098 or check out https://www.estrellabio.com.Estrella Immunopharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Estrella Immunopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Estrella Immunopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Estrella Immunopharma had very high historical volatility over the last 90 days | |
| Estrella Immunopharma may become a speculative penny stock | |
| Estrella Immunopharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Estrella Immunopharma generates negative cash flow from operations | |
| Estrella Immunopharma has a frail financial position based on the latest SEC disclosures | |
| About 72.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Estrella Immunopharma Appoints Dr. Cheng Liu as CEO - TipRanks |
Estrella Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.97 M.Estrella Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.64) | (0.10) | |
| Return On Capital Employed | (1.71) | (0.18) | |
| Return On Assets | (1.64) | (0.10) | |
| Return On Equity | (1.71) | (0.14) |
Management Efficiency
Estrella Immunopharma has return on total asset (ROA) of (1.2212) % which means that it has lost $1.2212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.7812) %, meaning that it created substantial loss on money invested by shareholders. Estrella Immunopharma's management efficiency ratios could be used to measure how well Estrella Immunopharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.1. The current year's Return On Capital Employed is expected to grow to -0.18. At present, Estrella Immunopharma's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 333.5 K, whereas Non Current Assets Total are forecasted to decline to 0.00.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.12 | 1.23 | |
| Tangible Book Value Per Share | 0.12 | 1.23 | |
| Enterprise Value Over EBITDA | (4.73) | (65.28) | |
| Price Book Value Ratio | 9.06 | 8.39 | |
| Enterprise Value Multiple | (4.73) | (65.28) | |
| Price Fair Value | 9.06 | 8.39 | |
| Enterprise Value | 34.6 M | 59.8 M |
The decision-making processes within Estrella Immunopharma are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 0.238 | Return On Assets (1.22) | Return On Equity (2.78) |
Technical Drivers
As of the 4th of December, Estrella Immunopharma shows the Coefficient Of Variation of 2746.31, mean deviation of 5.46, and Downside Deviation of 6.84. Estrella Immunopharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Estrella Immunopharma Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Estrella Immunopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Estrella Immunopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Estrella Immunopharma Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Estrella Immunopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Estrella Immunopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Estrella Immunopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zhang Hong over a month ago Discretionary transaction by Zhang Hong of tradable shares of Estrella Immunopharma subject to Rule 16b-3 | ||
Eureka Therapeutics, Inc. over two months ago Disposition of tradable shares by Eureka Therapeutics, Inc. of Estrella Immunopharma subject to Rule 16b-3 | ||
Wu Fan over six months ago Insider Trading | ||
Li Jianwei over six months ago Acquisition by Li Jianwei of 141970 shares of Estrella Immunopharma at 314700.0 subject to Rule 16b-3 | ||
Eureka Therapeutics Inc over a year ago Estrella Immunopharma exotic insider transaction detected |
Estrella Immunopharma Predictive Daily Indicators
Estrella Immunopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Estrella Immunopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 18108.9 | |||
| Daily Balance Of Power | (0.27) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 1.2 | |||
| Day Typical Price | 1.2 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) |
Estrella Immunopharma Forecast Models
Estrella Immunopharma's time-series forecasting models are one of many Estrella Immunopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Estrella Immunopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Estrella Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Estrella Immunopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Estrella shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Estrella Immunopharma. By using and applying Estrella Stock analysis, traders can create a robust methodology for identifying Estrella entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Estrella Immunopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Complementary Tools for Estrella Stock analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |